These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5581069)

  • 1. [Taurine in the treatment of ischemic cardiopathies and of progressive muscular dystrophy].
    Nigro G; Comi LI; Loiudice A; Petretta V
    Clin Ter; 1971 Feb; 56(4):347-59. PubMed ID: 5581069
    [No Abstract]   [Full Text] [Related]  

  • 2. [On a new trial therapy of progressive muscular dystrophy].
    Costagliola A; Di Lorenzo S
    Clin Ter; 1975 May; 73(3):251-9. PubMed ID: 1126142
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrocardiographic changes induced by taurine in coronary cardiopathies].
    De Rango F; Del Corso P
    Recenti Prog Med; 1968 Feb; 44(2):xix-li. PubMed ID: 5757400
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of a taurine-nucleotide-vitamin association on carbohydrate metabolism].
    De Lorenzi F
    Clin Ter; 1971 Jun; 57(5):441-70. PubMed ID: 5113575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiplatelet activity of picotamide in patients with chronic vascular pathology].
    Coto V; Carrieri P; Cocozza M; Oliviero U; Picano T; Spinoli G; Cacciatore L
    Minerva Cardioangiol; 1986 Sep; 34(9):601-4. PubMed ID: 2949164
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic activity of anti-platelet aggregation agents in arterial diseases].
    Delboy C; Jouve R; Escande M; Juhan I; Bouvenot G
    Sem Hop Ther; 1977 Nov; 53(9):431-40. PubMed ID: 341318
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetes mellitus and ischemic cardiopathies in the Senegalese].
    Koate P; Diouf S; Sylla M; Diop G
    Dakar Med; 1981; 26(3):347-56. PubMed ID: 7338132
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of pyridinolcarbamate in the treatment of diabetic angiopathies and atheromatous arteritis].
    Plauchu M; Bussy L; Rondelet J
    Lyon Med; 1972 Feb; 227(3):271-7. PubMed ID: 5037162
    [No Abstract]   [Full Text] [Related]  

  • 9. Apexcardiographic study on idiopathic cardiomyopathy, progressive muscular dystrophy, and ischemic heart disease.
    Suzuki T
    Kobe J Med Sci; 1982 Dec; 28(5-6):229-39. PubMed ID: 6892040
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of metformin in ischemic cardiopathy].
    Sgambato S; Varricchio M; Tesauro P; Passariello N; Carbone L
    Clin Ter; 1980 Jul; 94(1):77-85. PubMed ID: 7438725
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M
    Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long term observations in muscular dystrophy. Therapeutic influence of disease course in progressive muscular dystrophy (8 long term observations)].
    Schlenska GK; Kleine TO
    Med Welt; 1980 Jun; 31(25):940-4. PubMed ID: 6775171
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of electromyographic findings in patients with progressive muscular dystrophy during remetabolizing therapy.
    Buscaino GA; Caruso G
    Acta Neurol (Napoli); 1966; 21(1):33-45. PubMed ID: 4385733
    [No Abstract]   [Full Text] [Related]  

  • 14. [Coronary heart disease prevention in type 2 diabetic patients. What is the value of fibrates?].
    MMW Fortschr Med; 2002 Oct; 144(42):65. PubMed ID: 12534006
    [No Abstract]   [Full Text] [Related]  

  • 15. [Importance of the use of sodium lactate in the treatment of progressive muscular dystrophy].
    De Prá M
    Minerva Pediatr; 1967 Apr; 19(16):827-30. PubMed ID: 5613940
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hydroxyproline indicators before and after treatment of diabetic angiopathies].
    Spesivtseva VG; Mamaeva GG; Starosel'tseva LK; Tulemisov EU; Bokaneva IA
    Ter Arkh; 1978; 50(1):93-7. PubMed ID: 635809
    [No Abstract]   [Full Text] [Related]  

  • 17. [Features of potassium metabolism in progressive muscular dystrophy].
    Sitnikov VF; Leskova NN; Potashnikova NP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(11):1617-20. PubMed ID: 6779465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progressive muscular dystrophy].
    Tsuji S; Kato F; Osawa K
    Naika; 1967 Jun; 19(6):1301-3. PubMed ID: 4865513
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
    Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI
    Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the treatment of progressive muscular dystrophy with glucose insulin infusions].
    Blietz RJ
    Z Orthop Ihre Grenzgeb; 1965 Jul; 100(2):211-20. PubMed ID: 4221346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.